Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults
- Conditions
- Rabies
- Registration Number
- NCT02547727
- Lead Sponsor
- Queen Saovabha Memorial Institute
- Brief Summary
A four-site intradermal rabies booster vaccination in HIV - infected patients who have ever received primary rabies vaccination could improve their immune response to this kind of vaccine.
- Detailed Description
A four-site intradermal rabies booster vaccination has shown higher immune response than conventional intramuscular rabies booster vaccination in healthy persons. So, the investigators hypothesized the same outcome in HIV - infected patients.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
- HIV infected patients
- Age 18 - 60 years
- Received primary rabies immunization
- Have any active opportunistic infections
- Received blood or blood product within 3 months
- Allergy to vaccine or any vaccine components
- Received anti-malarial drugs
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Rabies neutralizing antibody titers Change from baseline of geometric mean titres of rabies neutralizing antibody titres at 2 weeks Rabies neutralizing antibody titers would be represented and compared by geometric mean titers (GMTs)
- Secondary Outcome Measures
Name Time Method Specific T cell response Change from baseline of percentages of rabies-antigen specific CD4+ T cells at 2 weeks Specific T cell response is measured by OX-40 assay
Cytokines assessment Change from baseline of cytokines levels at 1 week A few cytokines levels are measured by multiplex bead array assay
Trial Locations
- Locations (1)
Queen Saovabha Memorial Institute, Thai Red Cross Society
🇹🇭Bangkok, Thailand
Queen Saovabha Memorial Institute, Thai Red Cross Society🇹🇭Bangkok, ThailandSuda Sibunruang, M.D.Principal InvestigatorTerapong Tantawichien, M.D.Contact+66 2 2520161queensaovabha@hotmail.com